Brief: Reig Jofre Launches Dalbavancin For Adult Skin Infections In Europe
10/06/2026 11:15
BRIEF-Reig Jofre Launches Dalbavancin For Adult Skin Infections In Europe June 10 (Reuters) - Laboratorio Reig Jofre SA RJFE.MC:
LAUNCHES DALBAVANCIN IN EUROPE
DALBAVANCIN APPROVED FOR HOSPITAL USE IN ADULT SKIN INFECTIONS
DALBAVANCIN LAUNCH TARGETS UK, SPAIN, FRANCE, POLAND, SWEDEN AND OTHER EUROPEAN MARKETS
Further company coverage: RJFE.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Laboratorio Reig Jofre SA
See all newsSpanish stocks - Factors to watch on June 16
Brief: Reig Jofre Completes Scrip Dividend, Raises Capital
Brief: Reig Jofre Launches Dalbavancin For Adult Skin Infections In Europe
Brief: Reig Jofre Announces Execution Of Scrip Dividend
Brief: Reig Jofre Approves Terms For Capital Increase Via Scrip Dividend